Carl Zeiss Meditec AG (LON:0DHC)

Market Cap	3.95B
Revenue (ttm)	1.72B
Net Income (ttm)	129.86M
Shares Out	n/a
EPS (ttm)	1.47
PE Ratio	30.40
Forward PE	n/a
Dividend	0.94 (1.72%)
Ex-Dividend Date	Mar 27, 2025

Volume	38,254
Average Volume	24,459
Open	55.43
Previous Close	55.62
Day's Range	54.25 - 55.45
52-Week Range	37.27 - 102.13
Beta	1.14
RSI	51.91
Earnings Date	Feb 12, 2025

About Carl Zeiss Meditec AG

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1846
• Employees: 5,730
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0DHC

Financial Performance

In 2024, Carl Zeiss Meditec AG's revenue was 2.07 billion, a decrease of -1.11% compared to the previous year's 2.09 billion. Earnings were 178.73 million, a decrease of -38.45%.

Financial numbers in EUR